Jennifer M. Carter - 28 Oct 2021 Form 4 Insider Report for Augmedix, Inc.

Role
Director, 10%+ Owner
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Oct 2021
Net transactions value
+$350,000
Form type
4
Filing time
01 Nov 2021, 20:23:52 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Purchase $350,000 +87,500 +2.2% $4.00 4,022,606 28 Oct 2021 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held of record by McKesson Ventures LLC ("McKesson"). The Reporting Person, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.